Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Hematology & Oncology|February 8, 2019
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantationTheresa Kaeuferle, Ramona Krauss, Franziska Blaeschke, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
MicroRNA methodology: advances in miRNA technologiesTheresa Kaeuferle, Sabine Bartel, Stefan Dehmel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2020
CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy PosttransplantationTheresa Kaeuferle, Larissa Deisenberger, Lena Jablonowski, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4<sup>+</sup> and CD8<sup>+</sup> CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19<sup>+</sup> acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Frontiers in Immunology|April 25, 2022
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell FunctionFranziska Blaeschke, Eva Ortner, Dana Stenger, et al.
Experimental Hematology & Oncology|March 20, 2025
All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasoneTheresa Kaeuferle, Maximilian Zwermann, Nadine Stoll, et al.
Pediatric Hematology and Oncology|September 5, 2024
Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemicMira Reger, Kirsi Manz, Theresa Kaeuferle, et al.
Clinical & Translational Immunology|February 2, 2022
Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cellsTheresa Kaeuferle, Tanja A Stief, Stefan Canzar, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
Leukemia|March 24, 2020
Leukemia-induced dysfunctional TIM-3<sup>+</sup>CD4<sup>+</sup> bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patientsFranziska Blaeschke, Semjon Willier, Dana Stenger, et al.
Pageof 2